Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × NIH × Clear all

Phase

Phase 2 77 Phase 1 59 Phase 1/2 36 Phase NA 13 Phase 3 13 Phase 2/3 5 Phase EARLY_PHASE1 1 Phase 4 1

Status

Completed 10 Terminated 7 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 266 INDUSTRY 50 OTHER_GOV 6 NETWORK 2 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pirtobrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07428707 2026-03-13

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡